共 50 条
Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis
被引:23
|作者:
Monz, Brigitta U.
[1
]
Sachs, Paul
[2
,3
]
McDonald, Jeffrey
[4
]
Crawford, Bruce
[5
]
Nivens, Michael C.
[6
]
Tetzlaff, Kay
[6
,7
]
机构:
[1] Boehringer Ingelhelm GmbH, D-55216 Ingelheim, Germany
[2] Stamford Hosp, Stamford, CT 06902 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[4] Mapi Values, Boston, MA 02114 USA
[5] Mapi Values, Tokyo 1530064, Japan
[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[7] Univ Tubingen, Dept Sports Med, Med Clin, D-72076 Tubingen, Germany
关键词:
Cough and sputum assessment questionnaire;
COPD;
Chronic bronchitis;
Exacerbations;
Responsiveness;
OBSTRUCTIVE PULMONARY-DISEASE;
SMOKING-CESSATION;
TIME-COURSE;
BREATHLESSNESS;
VALIDATION;
MANAGEMENT;
RECOVERY;
SYMPTOMS;
D O I:
10.1016/j.rmed.2009.10.026
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: To assess the responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD and chronic bronchitis patients recovering from an acute exacerbation. The 20-item questionnaire with a 7-day recall assesses the frequency and severity of cough and sputum and their impact on everyday life in clinical (trial) settings. The four domains (cough/sputum symptom and impact) use scales from 0 to 100, with lower scores indicating higher symptom/impact levels. Methods: Outpatients were enrolled within 48 h of symptom onset of their exacerbation. Treatment was initiated at the discretion of the investigator, and patients observed for 6 weeks. During study visits, 59 eligible patients completed the CASA-Q at enrolment, week 1, 2 and 6. Responsiveness was assessed by calculating standardized effect sizes. Results: Of the 19 male and 40 female patients with a mean (standard deviation, SD) age of 61.1 (10.5) years, all were classified by their physician to have improved or recovered after six weeks. The mean (SD) CASA-Qsores for the cough symptom, cough impact, sputum symptom and sputum impact domains increased from 32.6 (21.0), 40.7 (22.4), 37.4 (20.1), 47.1 (24.2) at enrolment to 54.0 (19.8), 63.7 (21.3), 55.1 (19.0), 65.5 (20.5) at week 6, respectively. Standardized effect sizes for patients improved or recovered from their exacerbation at week 6 were above 1.0 for the cough domains and at least 0.77 for the sputum domains. Conclusions: The CASA-Q was responsive to symptom changes in patients recovering from an exacerbation. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文